Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Parvovirus-like particles in human sera.

Literature DB >> 46024

Parvovirus-like particles in human sera.

Y E Cossart, A M Field, B Cant, D Widdows.

Abstract

A parvovirus-like antigen has been found in sera of nine healthy blood-donors and two patients. Its pathogenicity is unknown, but 30% of adults possess specific antibody. The new agent can be confused with hepatitis-B antigen both morphologically and serologically.

Entities: Disease Species

Mesh：

Substances：

Year: 1975 PMID： 46024 DOI： 10.1016/s0140-6736(75)91074-0

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

170 in total

1. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.

Authors: J A Jordan
Journal: J Clin Microbiol Date: 2000-04 Impact factor: 5.948

Review 2. Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors: J R Kerr
Journal: Ann Rheum Dis Date: 2000-09 Impact factor: 19.103

3. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

Authors: John P Breinholt; Mousumi Moulik; William J Dreyer; Susan W Denfield; Jeffrey J Kim; John L Jefferies; Joseph W Rossano; Corey M Gates; Sarah K Clunie; Karla R Bowles; Debra L Kearney; Neil E Bowles; Jeffrey A Towbin
Journal: J Heart Lung Transplant Date: 2010-04-24 Impact factor: 10.247

Review 4. Parvovirus B19 infection in human pregnancy.

Authors: R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal: BJOG Date: 2010-10-13 Impact factor: 6.531

5. Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

Authors: H J O'Neill; P V Coyle
Journal: Arch Virol Date: 1992 Impact factor: 2.574

Parvovirus-like particles in human sera.

1. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.

Review 2. Pathogenesis of human parvovirus B19 in rheumatic disease.

3. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

Review 4. Parvovirus B19 infection in human pregnancy.

5. Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

6. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

7. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

8. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

9. A newly identified bocavirus species in human stool.

10. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.